Protein kinase B (PKB) or Akt is one of several second messenger kinases that are activated by cell attachment and growth factor signaling, and that transmit signals to the cell nucleus to inhibit apoptosis and thereby increase cell survival during proliferation. Other viral proteins target this pathway by increasing PKB/Akt phosphorylation, and this pathway has been implicated in the transformation of human keratinocytes by HPV E6 and E7, together with activated notch 1. Here, we examine how HPV E7 expression affects the phosphorylation of PKB. We show that HPV-16 E7 increases the level of phosphorylation of PKB in response to serum stimulation, by a mechanism independent of downregulation of PTEN phosphatase, a known inhibitor of the PI3K (PI3 kinase) pathway. The use of specific antibodies shows that some proportion of PKB/Akt that is phosphorylated both on threonine 308 and serine 473 is maintained in the presence of E7 in a PI3 kinase-independent manner, and is activated for phosphorylation of BAD, a known downstream target of PKB/Akt. Use of E7 mutants has ruled out both an inhibition of IGFBP-3, a known E7 target and PKB/Akt modulator, and the interaction of E7 with cellular pocket proteins, as being the mechanism for the PKB/Akt stimulation. PKB binds PP2A and is a known substrate of PP2A. Here, we show that HPV E7 also binds to both the 35 kDa catalytic and 65 kDa structural subunits of PP2A, an interaction that sequesters these subunits and inhibits their interaction with PKB, thereby maintaining PKB/Akt signaling by inhibiting its dephosphorylation.
Introduction
Human papillomaviruses are small, double-stranded DNA viruses that infect a variety of mucosal and cutaneous epithelial tissues. A subset of HPVs that are associated with the progression of infected lesions to malignancy are termed high risk, and are associated with a variety of malignancies, the most common of which is cervical carcinoma (zur Hausen, 1999) . Human papillomaviruses express two principal oncoproteins, E6 and E7, whose continued expression is required to maintain the oncogenic phenotype of cells derived from cervical tumors (Hawley-Nelson et al., 1989; Mu¨nger et al., 1989) . The function of E7 during the normal viral life cycle is to induce host cells to express proteins that the virus requires for replication of its own DNA. This leads to reactivation of the cell cycle in cells that would normally be undergoing differentiation and this leads to activation of host cell tumor suppressor pathways, which, in turn, are blocked by the E6 protein. The functions of these two viral proteins, E6 and E7, are reflected in many of the cellular proteins with which they interact; E7 interacts with members of the pocket protein family such as pRB (Dyson et al., 1989) , thus releasing transcriptional blocks on genes that express proteins required for cell-cycle progression, while E6's first identified target was the tumor suppressor p53 (Werness et al., 1990) . The interaction of E6 and E7 with these targets is considered fundamental to their oncogenic potential, although interaction with other cellular targets is clearly also required during malignant progression (Ishiwatari et al., 1994; Pim et al., 1994) .
In normal epithelial tissues, keratinocyte cell division is confined to the basal layer, where mitogenic signals are balanced by survival pathways transmitted through PI3 kinase (PI3K) and protein kinase B (PKB)/Akt. This pathway is one of a set of fundamental second messenger kinase pathways that drives survival pathways during cell proliferation in response to a variety of stimuli, including mitogenic signaling through growth factor receptors and cell attachment to the extracellular matrix (for a review see Brazil and Hemmings, 2001 ). The binding of growth factors to their receptors induces receptor phosphorylation, recruitment of the two subunits of PI3K, which then phosphorylate phosphatidylinositol diphosphate to triphosphate. This phospholipid compound then binds to the plekstrin homology (PH) domain of inactive, cytoplasmically-localized PKB causing it to relocate to the plasma membrane. This membrane localization of PKB is believed to induce a conformational change (Milburn et al., 2003) allowing it to be phosphorylated at serine 473 (ser473) at its C-terminus either by a PI3K-dependent kinase, or by a PI3K-independent kinase such as integrin-linked kinase (ILK) (Troussard et al., 2003) and at threonine 308 (thr308) by PI3K-dependent kinase 1 (PDK-1). PKB phosphorylated on both ser473 and thr308 is then fully active for phosphorylation of its downstream targets, some of which, like forkhead transcription factor 1 (FKHRL1) are phosphorylated in the cytoplasm and consequently blocked from entering the nucleus (Brunet et al., 1999) . Others, including GSK3a and b, p21/waf1, BAD, hTERT, BRCA-1 and hDM2 seem to be phosphorylated when activated PKB enters the nucleus, and at least some are consequently transported out of the nucleus (for reviews see Brazil and Hemmings, 2001; Hanada et al., 2004) . Antagonists to this pathway are numerous: the membrane localization of PKB/Akt is blocked by the dephosphorylation of phosphatidylinositol triphosphate by the PTEN phosphatase (Stambolic et al., 1998) and phosphorylated, activated PKB/Akt is dephosphorylated by PP2A (Andjelkovic et al., 1996) and PP1 (Xu et al., 2003) . In addition, when the PI3K/ PKB pathway is activated by insulin-like growth factor-1 (IGF-1), the activation can be inhibited by insulin-like growth factor binding protein 3 (IGFBP-3) (Huynh et al., 2002) . Interestingly IGFBP-3 has previously been demonstrated to be a target of the E7 proteins from high-risk mucosal HPVs (Mannhardt et al., 2000) . The pathway is also believed to be antagonized by RAF, an upstream component of the mitogen-activated protein kinase (MAPK) pathway (Westbrook et al., 2002) , which has been demonstrated to be activated in HPVinfected keratinocytes, in response to expression of the E5 gene (Pim et al., 1992; Gu and Matlashewski, 1995; Crusius et al., 1997; Johnston et al., 1999) . The PKB/ Akt pathway has already been demonstrated to be regulated by other viral proteins; polyomavirus middle T-Ag (Meili et al., 1998; Summers et al., 1998) , HIV-1 Tat (Borgatti et al., 1997) , hepatitis C nonstructural 5A protein (He et al., 2002) and most recently adenovirus 9 E4orf1 (Frese et al., 2003) . Previous studies have also shown that the E6 and E7 oncoproteins have the potential to synergize with activated notch-1 during the immortalization of human keratinocytes, along the PKB/Akt pathway (Rangarajan et al., 2001) . As a result of these observations, PKB/Akt seemed likely to be a possible target for modulation by the HPV oncogenes. Indeed, a previous study has shown that E7 can amplify PKB/Akt signaling to increase phosphorylation of p21 waf1 (Westbrook et al., 2002) . In support of these observations, in this study we also show that following serum stimulation, HPV-16 E7 and also HPV-11 E7 significantly increase the pool of phosphorylated, activated PKB in a PI3K-dependent manner, thus increasing its ability to phosphorylate downstream targets, such as the proapoptotic Bcl-2 family member, BAD (Datta et al., 1997) . However, HPV-16 E7 also appears to increase the level of thr308 and ser473-phosphorylated PKB by a PI3K-independent mechanism. Mutational analysis of E7 suggests that this activity is independent of its ability to bind pRB, whereas in vitro and in vivo binding and competition studies suggest that it may depend on an interaction with and sequestration of the 65 kDa structural and the 35 kDa catalytic subunits of PP2A, in a manner similar to papovavirus T antigens (Pallas et al., 1990) , thus preventing dephosphorylation of activated PKB/Akt.
Results
HPV-16 E7 expression increases the phosphorylation of ectopically expressed PKB in 293 and Saos-2 cells upon serum stimulation
To examine the effect of the E7 oncoprotein from the high-risk group of human papillomaviruses on the PKB/ Akt pathway, we transfected human 293 cells with empty vector or a plasmid expressing an N-terminally haemaglutanin (HA)-tagged version of PKB, in the presence or absence of a plasmid expressing wild-type HPV-16 E7. To control for plasmid uptake, a bgalactosidase expression plasmid was included in each transfection. After 24 h, the cells were placed in medium lacking serum and starved for 16 h to switch off growthfactor-mediated mitotic signaling pathways. Half of the transfected dishes were then pulsed with serum for 15 min to stimulate the signaling pathways, before all the dishes were harvested. Cellular proteins were separated by SDS-PAGE, electrophoretically transferred to nitrocellulose membranes, then probed with an antibody against the HA tag to quantify the total ectopically expressed PKB, along with an anti b-gal antibody to check for equal plasmid uptake and protein loading. After stripping, the membrane was then sequentially reprobed to quantify activated PKB using a pool of antibodies against thr308 and ser473-phosphorylated PKB and then for PTEN phosphatase. The results are shown in Figure 1a , where it can be seen that, although the level of the total, ectopically expressed PKB does not vary with the presence or absence of serum in the medium, serum stimulation of the transfected cells results in an increase in the level of activated, ectopically expressed PKB, as detected with the anti-phospho Akt antibodies. Interestingly, the level of PKB phosphorylation is further increased by E7 coexpression, and is even increased to a slight degree in the absence of serum. Because PTEN phosphatase is a major inhibitor of the PI3K pathway, we examined whether changes in the total protein levels of PTEN could be modulating PKB phosphorylation. The results show no significant variation of PTEN levels with the presence or absence of either E7 or serum, suggesting that the observed increase in PKB phosphorylation is not due to PTEN downregulation. In a separate experiment, we examined the effect of overexpression of the E7 protein from low-risk HPV-11 on PKB/Akt phosphorylation. The results, shown in Figure 1b , suggest that the increase in PKB/Akt phosphorylation is not restricted solely to the E7 proteins from high-risk HPV types. Since 293 cells are adenovirus transformed and express Ad E1A and E1B protein, we repeated the experiment in Saos-2 cells in order to eliminate the potential influence of the adenoviral proteins on HPV E7-induced PKB/Akt phosphorylation. The results, shown in Figure 1c , indicate that increased PKB/Akt phosphorylation can also occur in Saos-2 cells, in response to HPV-16 E7 expression, and is therefore not to due to Ad E1A or E1B expression.
The E7-induced increase in PKB phosphorylation is, in part, both PI3K independent and growth factor signaling independent
In an attempt to dissect the individual phosphorylation events, which lead to full activation of PKB, we examined the E7-induced phosphorylation of ectopically expressed PKB in 293 cells in the presence of the specific PI3K inhibitor Ly294002. The Western blot was probed sequentially with antibodies against the thr308 and ser473-phosphorylated forms of PKB separately. The results are shown in Figure 2 , where it can be seen that phosphorylated PKB/Akt migrates as two distinct bands. In the presence of E7 expression and serum stimulation, there is a striking increase both in ser473 and thr308-phosphorylated PKB/Akt. In the presence of the PI3K inhibitor, however, the upper band disappears, implying that this phosphorylation event is completely PI3K dependent. In contrast, while there is a reduction in the lower band, it is still present following PI3K inhibition and in higher amount than in the absence of E7, and in equivalent amounts as in the presence of E7 but the absence of serum stimulation. This suggests that E7 expression leads to an increase in PKB/Akt phosphorylation on both ser473 and thr308 by a mechanism that is both growth factor and PI3K independent.
The E7-induced increase in PKB phosphorylation is independent of its binding to the pocket proteins and insulin-like growth factor binding protein 3 (IGFBP-3)
To identify which regions of the E7 molecule might be involved in mediating its stimulation of PKB phosphorylation, we repeated the above experiment with wildtype E7 and three E7 mutants. Two of these mutants, p2Pro in the conserved domain 1 of E7 and p24Gly in the pocket protein-binding domain of conserved domain 2 have already been described (Banks et al., 1990) as has D79-83 in the cysteine loop of E7 . Mutant D79-83 has been demonstrated to be defective for binding to IGFBP-3 (Mannhardt et al., 2000) , whereas mutant p24Gly is defective for binding to pRB. Additionally, mutant p24 has previously been suggested to be defective for increasing PKB/Akt phosphorylation HPV-16 E7 induces PKB phosphorylation on both thr308 and ser473 in part in a PI3K-independent manner. Cells were treated as before with the addition, as indicated, of the PI3K inhibitor LY294002. After PAGE, Western blots were probed sequentially for ser473-phosphorylated PKB/Akt, thr308-phosphorylated PKB/Akt, then for HAPKB/Akt and b-galactosidase. PI3K-independent phosphorylated PKB/Akt bands are marked with arrows HPV E7 interaction with PP2A D Pim et al (Westbrook et al., 2002) . As can be seen in Figure 3 , however, all three E7 mutants were equally efficient at stimulating PKB/Akt phosphorylation, demonstrating that neither the binding of E7 to pocket proteins, nor its association with IGFBP-3 are required for stimulation of PKB/Akt phosphorylation. In fact, none of the point mutants nor small deletion mutants of E7 that were tried in this assay proved to be negative (data not shown), prompting us to speculate that more than one domain of E7 might be required for this activity, or, alternatively, that it might be dependent upon overall E7 conformation.
The increase in HPV-16 E7-mediated PKB/Akt phosphorylation leads to increased phosphorylation of the downstream target, BAD
To demonstrate that the E7-mediated phosphorylation of PKB/Akt on ser473 and thr308 led to an increase in its activation, we examined its ability to phosphorylate a downstream target, the proapoptotic Bcl-2 family protein BAD, which is inactivated by phosphorylation on serine 136 (ser136) by PKB/Akt (Datta et al., 1997) . Owing to the instability of endogenous BAD, we examined the phosphorylation of recombinant murine BAD expressed as a glutathione serine transferase (GST) fusion protein in response to HPV-16 E7 expression. 293 cells were transfected with constructs expressing HA-PKB/Akt, 16 E7 and GST Bad, as well as being serum-starved and serum pulsed as described previously. After harvesting and separation by SDS-PAGE, Western blots were probed for ser136-phosphorylated BAD and ser473-phosphorylated PKB/Akt. After stripping, the membranes were reprobed for total PKB/Akt and BAD. The results, shown in Figure 4 , demonstrate that the E7-dependent increase in PKB/Akt phosphorylation correlates with an increase in Bad phosphorylation on ser136, confirming that the HPV E7-induced phosphorylation of PKB/Akt results in its full activation.
HPV-16 E7 binds to both the catalytic and structural subunits of PP2A
Increased levels of phosphorylated PKB/Akt could be achieved either by an increase in the activities of kinases that phosphorylate PKB/Akt on thr308 and ser473, or by a decrease in PKB dephosphorylation (Hanada et al., 2004) . Previous studies suggest that in the context of proliferating keratinocyte stem cells, PKB/Akt activated signal transduction occurs via PI3K in an integrindependent manner (Velling et al., 2004) , and that this can be achieved, in part, through the integrin inhibition of PP2A dephosphorylation of PKB (Pankov et al., 2003) . Given that PP2A has been demonstrated to dephosphorylate PKB (Resjo et al., 2002) , we speculated that E7 might partially block thr308 and ser473 dephosphorylation of PKB by interacting with PP2A, inhibiting its function and thereby maintaining PKB signaling.
To investigate this possibility, we performed a pull down of in vitro translated PKB and HPV-16E7 with the PP2A Aa (PR65) and Ca (PR35) subunits expressed as GST fusions. The results, shown in Figure 5a , clearly show that both of the GST PP2A subunits bind to in vitro translated 16E7 and PKB/Akt. As further evidence for an interaction between E7 and PP2A, we performed pull downs of endogenous PP2A subunits from cell extracts using HPV-16 E7, HPV-11 E7 and the N-and C-terminal halves of HPV-16 as well as PBK/Akt, all expressed as GST fusion proteins. 293 whole-cell extracts were incubated with the GST fusion proteins and after washing, any bound proteins were separated by SDS-PAGE. After Western blotting, the membranes were probed with monoclonal antibodies against the C and A subunits of PP2A, and the results are shown in Figure 5b . As can be seen, both the GST 16 and 11E7 pull down both the C and A subunits of PP2A, although in both cases the interaction with the C subunit is the stronger of the two. Additionally, we see very weak pull down of both subunits with the GST 16E7 N-terminal fragment, but wild-type levels of pull down with the C-terminal fragment, indicating that all the residues in E7 that mediate the interaction with the PP2A subunits probably lie in the C-terminal loop of E7. When we performed pull-down assays with GST 16E7 using in vitro translated, radiolabeled PKB/Akt, we were unable to observe any interaction (data not shown). However, it is clear that GSTPKB binds extremely strongly to both of the endogenous PP2A subunits examined here. To show that the E7-PP2A interaction occurs in vivo, we transfected 293 cells with empty vector and with a vector expressing HA-tagged HPV-16 E7. After harvesting the cells, the extracts were incubated with mouse anti-HA antibodies covalently linked to agarose resin. After extensive washing, the resin was eluted into sample buffer and bound proteins were separated by PAGE, and transferred to nitrocellulose membranes. The membranes were then probed with the monoclonal antibodies against the PP2A A and C subunits. The results, shown in Figure 5c , demonstrate that HPV-16 E7 can interact with both PP2A subunits in vivo.
HPV-16 E7 competes with PKB/Akt for interaction with PP2A
The observation that both PKB and HPV-16 E7 bind to PP2A subunits led us to suspect that one way in which decreased PKB dephosphorylation might occur is by the sequestration of the PP2A subunits away from PKB by E7. To examine this possibility, we took extracts of 293 cells that had been transfected with empty vector and 293 cells that had been transfected with increasing amounts of the HAPKB-expressing plasmid and repeated the pull-down assay with GST 16E7 and GST 11E7. The results, shown in Figure 6a , demonstrate that with increasing expression of HAPKB, there is a decrease in the amount of PP2A bound by both GST E7s, suggesting that both HPV-11 and 16E7 maintain PKB/Akt phosphorylation by competing with it for binding to PP2A. Reprobing the blot with anti-HA antibodies confirmed that this reduction in PKB pull down was not due to the HAPKB binding to the GST E7, thus confirming our previous observation that E7 and PKB do not directly interact (data not shown). To confirm that E7 could compete for the binding of PP2A subunits to PKB/Akt, we performed a competition assay in vivo. 293 cells were transfected with empty vector or with an 11 or 16E7-expressing plasmid, together with the construct expressing HA-tagged PKB/Akt. After extraction, the cell lysates were incubated with anti-HA agarose resin to pull down the ectopically expressed HA PKB/Akt. After separation of the proteins by SDS-PAGE, a Western blot was performed to visualize the amounts of the PP2A subunits binding to the PKB/Akt. The results, shown in Figure 6b , show clearly that expression of both 11 and 16 E7 reduce the amount of both the A and C subunits of endogenous PP2A that can be bound by the coexpressed PKB/Akt, again confirming that both HPV-11 and 16 E7 maintain PKB/ Akt signaling through a similar mechanism The input controls show that there is no reduction in expression of either the A or C subunits in cells where either 11 or 16E7 is being over expressed.
Decreased PKB/Akt phosphorylation upon over expression of the PP2A Ca subunit PP2A has already been demonstrated to dephosphorylate PKB/Akt. Therefore, to analyse which family members might be involved, we overexpressed the PP2A Ca subunit along with ectopic HA-PKB/Akt and probed Western blots for PKB/Akt phosphorylation on both ser473 and thr308. The results are shown in Figure 7 , and demonstrate that, while Ca overexpression GST 16E7, GST11E7, GST PKB and GST 16E7 C-T, but not GST 16E7 N-T, bind to endogenous PP2A 65a and PP2A Ca in pull-down assays using 293 whole cell lysate. (c) HPV-11 and 16E7 bind to the PP2A 65a and Ca subunits in vivo. 293 cells were transfected with empty vector or vector-expressing HA-tagged 11 or 16E7. After extraction the cell extracts were incubated with anti-HA agarose conjugate, washed and after elution, separation by PAGE, and Western transfer, the amount of PP2A subunits binding to E7 were visualized by probing with the monoclonal antibodies to the PP2A subunits. Since the antibodies used for immunoprecipitation and western probing were both murine, heavy and light immunoglobulin chains can be visualized on the blot and have been marked HPV E7 interaction with PP2A D Pim et al leads to a decrease in ser473 phosphorylation, there is no decrease in thr308 phosphorylation, implying that if PP2A family members are required for complete PKB/ Akt dephosphorylation, then thr308 is likely to be dephosphorylated by another PP2A holoenzyme complex, or PP1, which may also be targeted by HPV E7.
Discussion
In normal keratinocytes, ras expression is required for basal cell proliferation but not for cells in the suprabasal layers where they are undergoing differentiation (Dajee et al., 2002) . This observation suggests that papillomaviruses require the activation of signal transduction pathways that are relevant to proliferation for their normal life cycle. Additionally, some of the earliest data on the transforming properties of the human papillomavirus oncoproteins E6 and E7 came from studies in primary rodent cells, showing that both E6 and E7 could cooperate with an activated oncogene, typically ras, to transform primary baby rat kidney (BRK) cells (Matlashewski et al., 1987) . As a result of all these observations, we have examined the effect of HPVE7 expression on the PI3K/PKB pathway. In this study, we have shown that in the presence of serum, under conditions when signal transduction pathways would be expected to be functional, HPV-16 E7 expression greatly enhances PKB/Akt phosphorylation. We also show that this effect is independent of any overall change in levels of PTEN phosphatase, a known inhibitor of PI3K function, independent of any interaction with IGFBP-3, a protein that has been implicated in modulation of PKB/Akt signaling and also previously identified as a cellular target of high-risk HPV E7, and independent of the interaction between E7 and the pocket proteins. This latter observation is in contrast to a study showing that, whereas wild-type HPV-16 E7 prevented Raf-mediated dephosphorylation of PKB/ Akt, leading to phosphorylation and mislocalization of p21, an E7 mutant defective for the interaction between E7 and pRb, was sensitive to Raf-mediated PKB/Akt dephosphorylation (Westbrook et al., 2002) , thus suggesting that more than one pathway converges on some downstream targets of PKB/Akt. The use of antibodies specific for the thr308 and ser473-phosphorylated forms of PKB has led to some indication of the mechanism involved. In the presence of E7, even under conditions of serum starvation, we observe increased phosphorylation on ser473 and thr308. Similarly, in the presence of E7 but with serum stimulation and treatment with the PI3K inhibitor LY294002, we observe a) Ectopically expressed PKB/Akt reduces the amount of endogenous PP2A 65a and PP2A Ca that bind to GST 16E7 and GST 11E7 in pull downs from transfected 293 cell extracts. 293 cells were untransfected or transfected with the indicated amounts of plasmid expressing HAPKB/Akt. After harvesting, 1 ml of each 293 extract was loaded as input control, while 30 ml of each were incubated with GST, GST 16E7 or GST 11E7 fusion proteins bound to Glutathione resin. After PAGE and Western transfer, membranes were probed with monoclonal antibodies against the PP2A 65a and Ca subunits. (b) Ectopically expressed HPV-11 and 16E7 reduce the amount of endogenous PP2A 65a and PP2A Ca that bind to ectopically expressed, HA-tagged PKB/Akt in 293 cells. 10 cm Petri dishes of 293 cells were transfected with 10 mg of empty vector, or vector expressing 11E7 or 16E7. After harvesting as previously described, 1 ml of each cell extract was loaded as input control and the remaining cell lysates were incubated for 4 h at RT with anti-HA agarose conjugate, extensively washed and after elution, separation by PAGE, and Western transfer the amounts of PP2A subunits binding to the HAPKB/Akt were visualized by probing with the monoclonal antibodies to the PP2A subunits. After stripping, the membranes were probed with anti-HA antibodies to visualize the HA-PKB/Akt expression levels Figure 7 Coexpression of PP2A Ca together with PKB/Akt leads to a reduction in PKB/Akt phosphorylation on ser473, but not on thr308. 293 cells were transfected with plasmids expressing HAPKB, with or without a plasmid expressing PP2A Ca. After harvesting, cell extracts were separated by PAGE, transferred to membranes and probed sequentially with antibodies against phospho thr308 PKB/Akt and against phospho ser473 PKB/Akt, then against HAPKB and b-galactosidase as described above maintenance of a certain level of PKB/Akt phosphorylation on both of these residues. This suggests that E7 expression induces a low level of PKB/Akt phosphorylation in a growth factor and PI3K-independent manner. We also demonstrate that the HPV-16 E7-mediated increase in PKB/Akt phosphorylation can be regarded as an increase in activation, since it leads to phosphorylation of a downstream target of PKB/Akt; the proapoptotic Bcl-2 family member BAD.
Increased levels of phosphorylated PKB can also result from a decrease in dephosphorylation. A study showing that beta 1 integrin, PKB and PP2A can form submembrane complexes in which PP2A dephosphorylation of PKB is blocked by an integrin internal domain, provides an example of one such mechanism (Pankov et al., 2003) and we speculated on whether E7 could perform a similar function in the absence of integrin expression. In this study, we demonstrate that both 16E7 and 11E7 bind strongly to the endogenous 35 kDa catalytic subunit and rather weakly to the 65 kDa structural subunit of endogenous PP2Aa both in vitro and in vivo. We also show that when PKB is ectopically expressed in 293 cells this inhibits the amount of endogenous subunits that pull down with both 16 and 11E7, demonstrating that the mechanism for inhibition of PKB/Akt dephosphorylation is probably the same for both viral proteins. Likewise, overexpression of both HPV-11 and 16 E7 also inhibit the amount of the PP2A subunits that interact with coexpressed HA-PKB/Akt in vivo. Lastly, we show that overexpression of the PP2A Ca subunit reduces ser473 but not thr308 phosphorylation of PKB/Akt; an observation that implies that another PP2A complex may dephosphorylate thr308. Current studies are aimed at identifying the subunits involved and analysing their ability to bind to E7. Taken together these data suggest that HPV E7 proteins can interact with and sequester PP2A subunits. It will obviously be of interest to determine whether HPV E7 can also affect the phosphorylation status of other proteins normally dephosphorylated by PP2A. The ability of HPV E7 to reduce PP2A-mediated dephosphorylation of a cellular target protein also demonstrates a striking parallel to one of the functions of polyamavirus small and middle T and SV40 small T antigens, which have been demonstrated to be able to bind to the 36 kDa and 63 kDa subunits of PP2A, thereby substituting for the 55 kDa regulatory subunit (Pallas et al., 1992) .
The relevance of the PI3K pathway for normal keratinocyte differentiation has been demonstrated by experiments showing that a dominant negative mutant of PI3K induced primary keratinocyte differentiation, as indicated by the expression of keratins 1 and 10, whereas a constitutively active mutant of PI3K-blocked differentiation (Sayama et al., 2002) . The proliferative pathway appears to be switched off and the differentiation pathway switched on in keratinocytes that have divided up from the basal layer; both effects mediated by their loss of contact with the basal membrane and consequent loss of interaction between integrins and laminins 5/10/11 (Fujisaki and Hattori, 2002; Pouliot et al., 2002) . The loss of integrin/laminin interaction inactivates PI3K and subsequently PKB/Akt, and it is noteworthy that one of the kinases that activate Akt by phosphorylation on ser473 is ILK (Delcommene et al., 1998) , and it has also been shown that ILK can phosphorylate ser473 of PKB/ Akt in the absence of PI3K-mediated phosphorylation of thr308 (Sun et al., 2002) . In the context of these observations, the finding that E7 proteins may increase the PI3K-independent phosphorylation of PKB/Akt, thereby inhibiting apoptosis during viral DNA amplification in the suprabasal layers of HPV-infected host keratinocytes is consistent with our understanding of the HPV life cycle, given that loss of contact with the basal membrane would tend to switch off host cell DNA synthesis as cells begin their normal differentiation schedule. While this model suggests an additional mechanism by which HPV E7 proteins might inhibit apoptosis during normal infection, it also raises the possibility that PKB/Akt activation might also contribute to the oncogenic potential of these viruses. Constitutive activation of the PI3K/PKB pathway has been implicated in several cancers (for a review see Stambolic et al., 1999) and while the ability of low-risk HPV-11 E7 to increase PKB/Akt phosphorylation demonstrates that this activity is more relevant to the general life cycle of papillomaviruses and thus insufficient to lead to cell transformation, it is likely that this activity could contribute to viral oncogenicity in the context of infection by a high-risk HPV.
Materials and methods

Plasmid expression vectors and transfections
Plasmid GW1 HA-PKB, for high-level expression of HAtagged, bovine PKB was the kind gift of Ron Xavier. pJ4O16 E7 and pJ4O11 E7 have previously been described (Storey et al., 1988) , as have the mutants pJ4O16 E7 p2Pro and pJ4O16 E7 p24Gly (Banks et al., 1990) . Plasmid construct GST PKB was cloned by PCR from GW1 HA-PKB, plasmids pGEX 16E7 and pGEX 11E7, expressing HPV-16 and 11E7, and plasmids pGEX 16E7 N-T, expressing the amino-terminal half of HPV-16 E7 from amino-acid 1-52, and pGEX 16E7 C-T, expressing the carboxy terminal portion of HPV-16 E7 from amino-acid 44-98, were all cloned by PCR, inserting the sequences into vector pGEX2T, in frame with the GST and sequenced to check for PCR errors. Plasmid pcDNA3 HA 16E7 was constructed by cloning an HA tag onto the N-terminus of HPV-16 E7 and inserting this into pcDNA3. pcDNA3 HA PP2A Ca expressing the 35 kDa catalytic subunit of PP2A was constructed by cloning an N-terminally HAtagged cDNA for PP2A Ca into plasmid pcDNA3, and was the kind gift of David Evans. Plasmid pEBG-mBAD, expressing recombinant murine BAD as a GST fusion protein was obtained from cell signaling technology. For expression as GST fusion proteins, the cDNAs for both the 35 kDa catalytic subunit and the 64 kDa structural subunit of PP2A were cloned into plasmid pGEX6.
293 cells were maintained in Dulbecco's modified Eagles' medium supplemented with foetal bovine serum to 10% concentration. All transfections were carried out in by calcium phosphate precipitation (Graham and van der Eb, 1973).
Western blot analysis
All transfections were carried out with a Lac Z plasmid in addition to those described above. Whole cell lysates were produced by lysing cells for 20 min on ice with a buffer containing 50 mM HEPES pH 7.0, 250 mM NaCl, 0.1% NP40, and 20 mg ml À1 aprotinin. Cells were left 20 min on ice with occasional vortexing, and then spun at 16 000 rcf for 1 min, after which supernatants were transferred to fresh tubes. Whole cell lysates, typically 50-100 mg, were subjected to SDS-PAGE separation on 7.5% gels, then electrophoretically transferred to nitrocellulose membranes (Schleicher and Schuell). Membranes were blocked by incubation with 10% milk powder in PBS. Western blots were probed with a mouse anti-b-galactosidase monoclonal antibody (Promega) to control for equal plasmid transfection efficiency and loading on gels. Antibodies against total or phosphorylated forms of PKB/Akt, and total or ser136-phosphorylated BAD (cell signaling technology) were used according to the manufacturers instructions. Primary antibody probes were amplified with biotinylated anti-rabbit or anti-mouse antibodies (Dako), depending on the primary antibody used, HRP linked Avidin (Dako), then the proteins visualized by enhanced chemiluminescence (Amersham) according to the manufacturer's instructions. When required for re-probing, membranes were stripped by incubating for 1hr at 651C in a buffer containing 2% SDS, 60 mM Tris pH 6.8, 100 mM b-mercaptoethanol, followed by several washes in distilled water.
GST pull downs, and co-immunoprecipitations
For pull downs from whole cell lysates, whole-cell lysates were prepared as for Western blot analysis. GST fusion proteins were prepared as previously described (Smith and Johnson, 1988) . Typically, 30 mg of cell extract was incubated with the requisite amount of GST fusion protein bound to Glutathione agarose (Sigma) for 2 h at room temperature, followed by five washes in lysis buffer. Bound proteins were eluted by boiling in loading buffer then separated by SDS-PAGE; 1 mg of wholecell extract was always run as control for identification of PP2A subunits. After Western transfer as described above, membranes were probed with monoclonal antibodies against the PP2A Ca and 65a subunits at 1 in 1000 concentration in PBS/5% Tween/10% milk, followed by incubation with biotinylated anti-mouse secondary antibodies (Dako), Avidin (Dako) and ECL reagent as described above.
Pull downs with in vitro transcribed/translated and radiolabeled proteins were performed as previously described .
For co-immunoprecipitations, 293 cells were transfected with 5 mg of either pcDNA3 or pcDNA3 HA16E7, expressing HA-tagged 16E7. After harvesting as described above, cell extracts were incubated with 10 ml of anti-HA agarose conjugate (Sigma) for 3 h at room temperature, followed by five washes in extraction buffer. Immunoprecipitates were eluted from the agarose by incubation for 10 min at þ 41C in sample buffer. After spinning to pellet the agarose beads, the eluates were removed to fresh tubes, heated at 901C for 2 min before PAGE separation. After Western transfer, co-immunoprecipitates were visualized by probing the membrane with mouse monoclonal antibodies against the PP2A subunits as described above.
Monoclonal antibody preparation
cDNA encoding full-length human PP2A A (PR65) or fulllength PP2A C (PR35) were inserted into the pQE 30 bacterial expression vector (Qiagen) to generate fusion proteins containing a 6 Â His tag at the N-terminus of the inserted sequence. Protein was expressed and isolated by the methods described by the vector manufacturer. Young Balb/c Â CBA F1 crossed mice were immunized by subcutaneous injection with 100 mg of fusion protein emulsified with an equal volume of Titremax Gold (CytRx Corporation). The immunization was repeated three times at 2-3 monthly intervals, then the mice rested for 6 months. A further 100 mg of fusion protein in phosphatebuffered saline was injected intraperitoneally at 6 and 3 days prior to killing. Hybridoma lines were then established by fusing splenocytes from the immunized animal with the myeloma line Sp2/0-Ag14 by polyethylene glycol treatment using conventional procedures (Harlow and Lane, 1988) . Individual wells were screened for antibody production by a modified dot blot procedure using bacterially expressed fusion protein (Dilworth and Horner, 1993) , and single cell cloned a minimum of three times before being grown for antibody isolation. Each monoclonal antibody was screened for specificity by Western blotting against total proteins from SDS derived tissue culture cell lysates. Lines F2 5G4 was used for PP2A C and C5 3D10 for PP2A A detection.
